Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yan Qiu

Showing results (911-920 of 1,377) with videos related to

Pageof 138
Sort By:
Expert Opinion on Drug Safety|September 28, 2021
Association between cyclin-dependent kinase 4/6 inhibitors and venous thromboembolism: analysis of F.A.E.R.S. dataMing-Ming Yan, Shu-Shan Wu, Yu-Peng Qi, et al.
Journal of Natural Products|March 31, 2021
Diverse Polycyclic Polyprenylated Acylphloroglucinol Congeners with Anti-Nonalcoholic Steatohepatitis Activity from <i>Hypericum forrestii</i>Wei-Jia Lu, Wen-Jun Xu, Mei-Hui Zhang, et al.
Cardiovascular Diabetology|November 5, 2024
Healthy longevity-associated protein improves cardiac function in murine models of cardiomyopathy with preserved ejection fractionValeria Vincenza Alvino, Sadie Slater, Yan Qiu, et al.
Frontiers in Oncology|January 1, 2024
Clinical efficacy and safety evaluation of camrelizumab plus lenvatinib in adjuvant therapy after hepatocellular carcinoma surgeryXudan Wang, Weiwei Cao, Yan Qiu, et al.
Journal of Affective Disorders|December 30, 2023
Osteoporosis and low bone mass among schizophrenia and bipolar disorder: A cross-sectional study with newly diagnosed, drug-naïve subjectsSujuan Li, Xiaoqin Chen, Yan Qiu, et al.
Zhongguo Zhong Yao Za Zhi = Zhongguo Zhongyao Zazhi = China Journal of Chinese Materia Medica|May 30, 2024
[Mechanism of tetramethylpyrazine intervention with ischemia-reperfusion rats based on Nrf2/HO-1/CXCR4 pathway through regulating neural stem cell migration]Zhuo-Hang Li, Dong Wang, Yan-Qiu Wang, et al.
Zhongguo Zhong Yao Za Zhi = Zhongguo Zhongyao Zazhi = China Journal of Chinese Materia Medica|May 30, 2024
[Mechanism of tetramethylpyrazine combined with neural stem cells transplantation on cerebral ischemia-reperfusion rats]Ming-Zhu Qi, Yan-Qiu Wang, Dong Wang, et al.
Heliyon|May 26, 2023
MiR-21 alleviates renal tubular epithelial cells injury induced by ischemia by targeting TLR4Xiu-Juan Liu, Jin-Lei Lv, Xin Zou, et al.
Zhongguo Shi Yan Xue Ye Xue Za Zhi|March 3, 2011
[Angioimmunoblastic T-cell lymphoma with large granular lymphocytosis]Jian-Ning Wang, Ping Zhang, Liu-Bo Zhang, et al.
Oncotarget|August 18, 2016
MiR-4653-3p and its target gene FRS2 are prognostic biomarkers for hormone receptor positive breast cancer patients receiving tamoxifen as adjuvant endocrine therapyXiaoRong Zhong, GuiQin Xie, Zhang Zhang, et al.
Pageof 138

Showing results (911-920 of 1,377) with videos related to

Sort By:
Pageof 138
Expert Opinion on Drug Safety|September 28, 2021
Association between cyclin-dependent kinase 4/6 inhibitors and venous thromboembolism: analysis of F.A.E.R.S. dataMing-Ming Yan, Shu-Shan Wu, Yu-Peng Qi, et al.
Journal of Natural Products|March 31, 2021
Diverse Polycyclic Polyprenylated Acylphloroglucinol Congeners with Anti-Nonalcoholic Steatohepatitis Activity from <i>Hypericum forrestii</i>Wei-Jia Lu, Wen-Jun Xu, Mei-Hui Zhang, et al.
Cardiovascular Diabetology|November 5, 2024
Healthy longevity-associated protein improves cardiac function in murine models of cardiomyopathy with preserved ejection fractionValeria Vincenza Alvino, Sadie Slater, Yan Qiu, et al.
Frontiers in Oncology|January 1, 2024
Clinical efficacy and safety evaluation of camrelizumab plus lenvatinib in adjuvant therapy after hepatocellular carcinoma surgeryXudan Wang, Weiwei Cao, Yan Qiu, et al.
Journal of Affective Disorders|December 30, 2023
Osteoporosis and low bone mass among schizophrenia and bipolar disorder: A cross-sectional study with newly diagnosed, drug-naïve subjectsSujuan Li, Xiaoqin Chen, Yan Qiu, et al.
Zhongguo Zhong Yao Za Zhi = Zhongguo Zhongyao Zazhi = China Journal of Chinese Materia Medica|May 30, 2024
[Mechanism of tetramethylpyrazine intervention with ischemia-reperfusion rats based on Nrf2/HO-1/CXCR4 pathway through regulating neural stem cell migration]Zhuo-Hang Li, Dong Wang, Yan-Qiu Wang, et al.
Zhongguo Zhong Yao Za Zhi = Zhongguo Zhongyao Zazhi = China Journal of Chinese Materia Medica|May 30, 2024
[Mechanism of tetramethylpyrazine combined with neural stem cells transplantation on cerebral ischemia-reperfusion rats]Ming-Zhu Qi, Yan-Qiu Wang, Dong Wang, et al.
Heliyon|May 26, 2023
MiR-21 alleviates renal tubular epithelial cells injury induced by ischemia by targeting TLR4Xiu-Juan Liu, Jin-Lei Lv, Xin Zou, et al.
Zhongguo Shi Yan Xue Ye Xue Za Zhi|March 3, 2011
[Angioimmunoblastic T-cell lymphoma with large granular lymphocytosis]Jian-Ning Wang, Ping Zhang, Liu-Bo Zhang, et al.
Oncotarget|August 18, 2016
MiR-4653-3p and its target gene FRS2 are prognostic biomarkers for hormone receptor positive breast cancer patients receiving tamoxifen as adjuvant endocrine therapyXiaoRong Zhong, GuiQin Xie, Zhang Zhang, et al.
Pageof 138